Price target
13.970.000.00%
The 4 analysts offering 1 year price forecasts for AT20 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to AT20 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
AT20 EPS for the last quarter is −2.63 EUR despite the estimation of −1.70 EUR. In the next quarter EPS is expected to reach −3.70 EUR. Track more of ATARA BIOTHERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter ATARA BIOTHERAPEUTICS INC revenue is expected to reach 16.45 M EUR. Check out ATARA BIOTHERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, AT20 price target is 13.97 EUR with a max estimate of 19.88 EUR and a min estimate of 9.47 EUR. Check if this forecast comes true in a year, meanwhile watch ATARA BIOTHERAPEUTICS INC stock price chart and keep track of the current situation with AT20 news and stock market news.
We've gathered opinions of 5 analysts rating AT20 stock in the past 3 months. After counting all points of view, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.